| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 915.32K | 872.50K | 29.82K | 72.86K | 339.67K | 2.35K |
| Gross Profit | 452.53K | 192.49K | -385.06K | -780.48K | -275.04K | -124.44K |
| EBITDA | -7.64M | -9.35M | -11.08M | -13.75M | -11.27M | -3.73M |
| Net Income | -8.19M | -10.04M | -11.70M | -14.41M | -38.69M | -3.87M |
Balance Sheet | ||||||
| Total Assets | 16.87M | 18.40M | 22.59M | 33.29M | 37.98M | 30.25M |
| Cash, Cash Equivalents and Short-Term Investments | 1.33M | 121.48K | 3.52M | 10.36M | 26.68M | 3.09M |
| Total Debt | 1.89M | 680.47K | 1.24M | 1.61M | 2.23M | 404.32K |
| Total Liabilities | 5.18M | 3.65M | 2.41M | 2.90M | 3.44M | 2.79M |
| Stockholders Equity | 11.69M | 14.75M | 20.17M | 30.38M | 34.55M | 27.46M |
Cash Flow | ||||||
| Free Cash Flow | -5.80M | -6.28M | -8.37M | -15.23M | -11.97M | -2.05M |
| Operating Cash Flow | -5.42M | -6.28M | -8.05M | -12.96M | -7.99M | -1.79M |
| Investing Cash Flow | 2.40M | 358.65K | 1.88M | -2.31M | -7.25M | -1.23M |
| Financing Cash Flow | 1.42M | 2.52M | -665.47K | -1.05M | 38.82M | 5.31M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | C$213.09M | -13.96 | -10.51% | ― | 2.48% | -53.76% | |
58 Neutral | C$48.34M | -29.63 | ― | ― | -21.89% | 26.36% | |
58 Neutral | C$88.83M | 129.17 | 0.87% | ― | 2.14% | -83.06% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
40 Neutral | C$107.31M | -12.74 | -52.95% | ― | 2225.73% | 25.94% | |
40 Underperform | C$54.81M | -16.90 | -2846.90% | ― | ― | 10.97% | |
26 Underperform | C$80.65M | -32.97 | ― | ― | ― | 10.49% |
Zentek Ltd. has appointed Mohammed Jiwan as the new Chief Executive Officer, effective December 1, 2025. Jiwan brings over 20 years of experience in operational and capital markets leadership, particularly in technology, healthcare, and life sciences. His appointment is seen as a strategic move to guide Zentek into its next phase of growth, focusing on unlocking the full value of its technologies and assets. The company also announced the granting of stock options and restricted share units to certain officers, directors, and consultants, indicating a commitment to aligning leadership incentives with shareholder value creation.
Zentek Ltd. has received a notice of reassessment from the Canada Revenue Agency (CRA) concerning its 2019 financial year, related to its flow-through financings. The CRA has reclassified approximately $199,000 of Canadian exploration expenses, resulting in a tax assessment of $22,481.89. Zentek is required to indemnify subscribers affected by the reassessment, with a maximum liability of $427,000. This reassessment may impact Zentek’s financial obligations and its relationship with investors involved in the flow-through financings.
Zentek Ltd. has developed a new Graphite Gel-Based Fire-Retardant product designed to protect homes from wildfires. The product, which combines rapid gelation and intumescent components, has been licensed exclusively to Altek Advanced Materials Inc. for commercialization in the US under the name GraphGel™. The coating has been tested to achieve a Class A fire rating and can be rapidly applied to structures, offering significant protection. This development addresses the growing need for effective fire management solutions amid increasing wildfire incidents.
Zentek Ltd. has successfully closed a non-brokered private placement of units, raising gross proceeds of $2,479,227. The funds will be allocated for general and administrative corporate purposes. This financial move is expected to bolster the company’s operational capabilities and potentially enhance its market positioning. The offering included common shares and warrants, with certain directors participating, marking it as a related party transaction under regulatory guidelines.
Zentek Ltd. has announced an increase in its non-brokered private placement to raise up to $2,500,000, with each unit priced at $1.06. The proceeds will be used for working capital and general corporate purposes. Each unit comprises one common share and two half-warrants, which can be converted into common shares at specified prices and conditions. The offering is subject to regulatory approvals and includes a hold period for the issued securities.
Zentek’s subsidiary, Albany Graphite Corp., announced successful results from nuclear suitability testing of its ultra-high purity graphite, confirming its potential use in the nuclear energy industry. The tests demonstrated that Albany graphite meets or exceeds nuclear-grade requirements in areas such as particle size distribution, compressibility, resistivity, and friction, highlighting its reliability and safety for demanding nuclear applications.
Zentek Ltd. has announced a non-brokered private placement aiming to raise up to $2,000,000 through the issuance of units priced at $1.06 each. The proceeds will be used for working capital and general corporate purposes. Each unit includes common shares and purchase warrants, with specific terms for Series A and Series B warrants. This move is part of Zentek’s strategy to bolster its financial resources and support its ongoing operations and development projects. Additionally, the company has granted stock options and restricted share units to its officers, directors, and employees, further aligning their interests with the company’s growth objectives.
Zentek Ltd. announced the successful voting results from its annual and special meeting of shareholders, where all resolutions were approved, including the election of board members and the appointment of BDO Canada LLP as auditors. Notably, John Snisarenko was appointed as the new Chair of the Board, succeeding Eric Wallman. This leadership change is seen as a strategic move to support Zentek’s growth ambitions and enhance shareholder value as the company transitions its CEO and continues to develop its innovative technologies.
Zentek Ltd. announced a leadership transition with CFO Wendy Ford stepping in as Interim CEO following the resignation of former CEO Greg Fenton. The company is actively searching for a new CEO to guide its next growth phase. Zentek’s ZenGUARD™ Enhanced Air Filters have demonstrated superior performance in removing infectious aerosols, aligning with ASHRAE standards, and are being positioned for widespread adoption in Canada through government procurement and partnerships. This strategic move aims to enhance market penetration and accelerate revenue growth, particularly in sectors like healthcare and education.
Zentek’s subsidiary, Albany Graphite Corp., has achieved a significant milestone by purifying Albany graphite to an ultra-high 5N purity level, making it suitable for nuclear applications. This development positions Albany graphite as a rare natural alternative to synthetic graphite, with potential implications for the nuclear energy sector, especially as countries like Canada and the U.S. expand their nuclear energy capacities. The purification process, which avoids halogen gases, offers a cost-effective and environmentally friendly solution, enhancing the material’s appeal for high-growth markets.
Zentek Ltd. has successfully completed the first in vivo tests of its lead candidate countermeasure for seasonal influenza (H1N1) using multivalent aptamer technology. The testing, part of the Innovative Solutions Canada Testing Stream, showed promising results, with treated animals exhibiting improved clinical scores and higher survival rates compared to the control group. This development, supported by a $1.1 million award from the Government of Canada, marks a significant step in Zentek’s efforts to address both seasonal and potentially pandemic influenza strains, positioning the company as a key player in the advanced medical technologies sector.
Zentek Ltd. has announced an updated slate of independent director nominees for its upcoming annual general and special meeting. The new nominees include Matt Fontes and Pete Gettinby, who bring expertise in building innovation and renewable energy, respectively. This strategic update aims to enhance Zentek’s board with diverse skills and experiences, potentially strengthening its market position and operational capabilities.